Fujian Kerui Pharmaceutical Co., Ltd. FDA Record

Summary

FDA record by year

Fujian Kerui Pharmaceutical Co., Ltd.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Recent FDA inspections

6 inspections from Feb 19, 2009 to Apr 25, 2025.

NAI

No objectionable conditions or practices were found during the inspection.

VAI

Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.

OAI

Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

2 inspected sites, newest inspection first.

Fujian Kerui Pharmaceutical Co., Ltd. and the FDA: common questions

Has Fujian Kerui Pharmaceutical Co., Ltd. received an FDA warning letter?

No FDA warning letter addressed to the name "Fujian Kerui Pharmaceutical Co., Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Fujian Kerui Pharmaceutical Co., Ltd. received an FDA Form 483?

FDA has not published a Form 483 for "Fujian Kerui Pharmaceutical Co., Ltd." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Fujian Kerui Pharmaceutical Co., Ltd.?

The most recent FDA inspection on file ended Apr 25, 2025 at Fuqing, China and was classified VAI. FDA has 6 inspections of Fujian Kerui Pharmaceutical Co., Ltd. on file.